Vaccine News and Research

Latest Vaccine News and Research

Vaccinogen chooses Clinipace Worldwide to manage pivotal phase 3b confirmatory trial for OncoVAX

Vaccinogen chooses Clinipace Worldwide to manage pivotal phase 3b confirmatory trial for OncoVAX

New breakthrough: Seaweed for treatment of swine flu

New breakthrough: Seaweed for treatment of swine flu

Boehringer Ingelheim, Micromet enter collaboration for new BiTE antibody for multiple myeloma

Boehringer Ingelheim, Micromet enter collaboration for new BiTE antibody for multiple myeloma

Older men who receive pneumococcal vaccine not less likely to have heart attack, stroke: JAMA

Older men who receive pneumococcal vaccine not less likely to have heart attack, stroke: JAMA

Cryo-EM images shed light on virus structure, function

Cryo-EM images shed light on virus structure, function

Vical commences enrollment in Phase 1 trial of Vaxfectin DNA pandemic influenza vaccine

Vical commences enrollment in Phase 1 trial of Vaxfectin DNA pandemic influenza vaccine

Archivel Farma to start phase II clinical trials of RUTI vaccine for Latent Tuberculosis

Archivel Farma to start phase II clinical trials of RUTI vaccine for Latent Tuberculosis

Abbott announces opening of Asia-Pacific Nutrition R&D Center

Abbott announces opening of Asia-Pacific Nutrition R&D Center

UK GTAC, MHRA approve Scancell's Phase I clinical trial of SCIB1 DNA ImmunoBody vaccine

UK GTAC, MHRA approve Scancell's Phase I clinical trial of SCIB1 DNA ImmunoBody vaccine

Idera Pharmaceuticals reports net loss of $1.9M for first-quarter 2010

Idera Pharmaceuticals reports net loss of $1.9M for first-quarter 2010

Widespread support for a full flu vaccine side effects enquiry

Widespread support for a full flu vaccine side effects enquiry

Celldex reports net loss of $6.6 million for first-quarter 2010

Celldex reports net loss of $6.6 million for first-quarter 2010

Personalized vaccine processed using tumor tissue promising for brain tumor treatment

Personalized vaccine processed using tumor tissue promising for brain tumor treatment

Merck reports non-GAAP EPS of $0.83 for first-quarter 2010

Merck reports non-GAAP EPS of $0.83 for first-quarter 2010

MicroStockProfit.com releases investment report on Vical

MicroStockProfit.com releases investment report on Vical

NIH awards $3.4M grant for preclinical development of novel Staphylococcus aureus vaccine

NIH awards $3.4M grant for preclinical development of novel Staphylococcus aureus vaccine

National Cancer Institute data: San Francisco has highest rate of liver cancer in the nation

National Cancer Institute data: San Francisco has highest rate of liver cancer in the nation

Novel combined immunotherapy promising for treatment of malignant brain tumors

Novel combined immunotherapy promising for treatment of malignant brain tumors

Johns Hopkins researchers identify a key protein that triggers sarcoidosis

Johns Hopkins researchers identify a key protein that triggers sarcoidosis

H1N1 positivity highest among children

H1N1 positivity highest among children

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.